Clinical trialNo phase (not a drug trial)Completed
Whipple Protein Study
High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy
- Outcome
- Finished, no results posted
- Phase
- No phase (not a drug trial)
- Status
- Completed
- Study type
- Interventional
- Start
- 20 August 2019
- Ended
- 15 November 2022
- Enrollment
- 22 participants
- Sites
- 1
- Primary outcomes
- Complications
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 7 May 2025
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Study investigators aim to assess the effect of providing high-protein nutritional supplementation before and after surgery
Detailed description public domain (ClinicalTrials.gov)
Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many potential complications. Many people undergoing PD are malnourished due to their underlying medical condition or difficulties eating in the face of abdominal pain or obstruction from pancreatic disease. This study aims to assess the effect of high-protein dietary supplementation in improving perioperative nutrition and decreasing complications. We will randomize PD patients to an experimental arm in which they take a nutritional, high-protein supplement for 2 weeks before and after surgery, or to a control arm, where they will take a standard postoperative diet without supplementation. Outcomes and nutritional parameters will be examined after they complete the supplements.